A detailed history of Wolverine Trading, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 54,278 shares of HUMA stock, worth $287,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,278
Previous 40,030 35.59%
Holding current value
$287,130
Previous $192,000 53.65%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.11 - $9.46 $72,807 - $134,786
14,248 Added 35.59%
54,278 $295,000
Q2 2024

Aug 14, 2024

BUY
$2.87 - $9.1 $60,465 - $191,718
21,068 Added 111.11%
40,030 $192,000
Q1 2024

May 15, 2024

SELL
$2.57 - $4.84 $4,189 - $7,889
-1,630 Reduced 7.92%
18,962 $58,000
Q4 2023

Feb 14, 2024

BUY
$1.99 - $3.12 $17,374 - $27,240
8,731 Added 73.61%
20,592 $58,000
Q3 2023

Nov 15, 2023

BUY
$2.75 - $4.48 $32,617 - $53,137
11,861 New
11,861 $34,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $545M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.